Thiopurine treatment in patients with Crohn's disease leads to a selective reduction of an effector cytotoxic gene expression signature revealed by whole-genome expression profiling

G. Bouma; J.M. Baggen; A.A. van Bodegraven; C.J.J. Mulder; G. Kraal; A. Zwiers; A.J. Horrevoets; C.T.M. van der Pouw Kraan

doi:10.1016/j.molimm.2013.01.015

Thiopurine treatment in patients with Crohn's disease leads to a selective reduction of an effector cytotoxic gene expression signature revealed by whole-genome expression profiling

G. Bouma
, J.M. Baggen
, A.A. van Bodegraven
, C.J.J. Mulder
, G. Kraal
, A. Zwiers
, A.J. Horrevoets
, C.T.M. van der Pouw Kraan

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	472-481
Journal	Molecular immunology
Volume	54
Issue number	3-4
DOIs	https://doi.org/10.1016/j.molimm.2013.01.015
Publication status	Published - 2013

Access to Document

10.1016/j.molimm.2013.01.015

Cite this

Bouma, G., Baggen, J. M., van Bodegraven, A. A., Mulder, C. J. J., Kraal, G., Zwiers, A., Horrevoets, A. J., & van der Pouw Kraan, C. T. M. (2013). Thiopurine treatment in patients with Crohn's disease leads to a selective reduction of an effector cytotoxic gene expression signature revealed by whole-genome expression profiling. Molecular immunology, 54(3-4), 472-481. https://doi.org/10.1016/j.molimm.2013.01.015

@article{395faac3f747460abe3d1db198686001,

title = "Thiopurine treatment in patients with Crohn's disease leads to a selective reduction of an effector cytotoxic gene expression signature revealed by whole-genome expression profiling",

author = "G. Bouma and J.M. Baggen and \{van Bodegraven\}, A.A. and C.J.J. Mulder and G. Kraal and A. Zwiers and A.J. Horrevoets and \{van der Pouw Kraan\}, C.T.M.",

year = "2013",

doi = "10.1016/j.molimm.2013.01.015",

language = "Undefined/Unknown",

volume = "54",

pages = "472--481",

journal = "Molecular immunology",

issn = "0161-5890",

publisher = "Elsevier Limited",

number = "3-4",

}

Bouma, G, Baggen, JM, van Bodegraven, AA, Mulder, CJJ, Kraal, G, Zwiers, A, Horrevoets, AJ & van der Pouw Kraan, CTM 2013, 'Thiopurine treatment in patients with Crohn's disease leads to a selective reduction of an effector cytotoxic gene expression signature revealed by whole-genome expression profiling', Molecular immunology, vol. 54, no. 3-4, pp. 472-481. https://doi.org/10.1016/j.molimm.2013.01.015

Thiopurine treatment in patients with Crohn's disease leads to a selective reduction of an effector cytotoxic gene expression signature revealed by whole-genome expression profiling. / Bouma, G.; Baggen, J.M.; van Bodegraven, A.A. et al.
In: Molecular immunology, Vol. 54, No. 3-4, 2013, p. 472-481.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Thiopurine treatment in patients with Crohn's disease leads to a selective reduction of an effector cytotoxic gene expression signature revealed by whole-genome expression profiling

AU - Bouma, G.

AU - Baggen, J.M.

AU - van Bodegraven, A.A.

AU - Mulder, C.J.J.

AU - Kraal, G.

AU - Zwiers, A.

AU - Horrevoets, A.J.

AU - van der Pouw Kraan, C.T.M.

PY - 2013

Y1 - 2013

U2 - 10.1016/j.molimm.2013.01.015

DO - 10.1016/j.molimm.2013.01.015

M3 - Article

C2 - 23454163

SN - 0161-5890

VL - 54

SP - 472

EP - 481

JO - Molecular immunology

JF - Molecular immunology

IS - 3-4

ER -